v3.26.1
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses    
Research and development $ 29,183,000 $ 19,984,000
General and administrative 12,266,000 7,080,000
Total operating expenses 41,449,000 27,064,000
Loss from operations (41,449,000) (27,064,000)
Other income (expense)    
Interest income 3,106,000 1,317,000
Change in fair value of redeemable convertible preferred stock tranche liability (1,526,000) (3,417,000)
Total other income (expense) 1,580,000 (2,100,000)
Loss before income tax (39,869,000) (29,164,000)
Income tax provision 0 0
Net loss (39,869,000) (29,164,000)
Comprehensive loss $ (39,869,000) $ (29,164,000)
Net loss per share    
Weighted average common stock outstanding - basic (in shares) 2,217,104 1,788,211
Weighted average common stock outstanding - diluted (in shares) 2,217,104 1,788,211
Net loss per share of common stock - basic (in dollars per share) $ (17.98) $ (16.31)
Net loss per share of common stock - diluted (in dollars per share) $ (17.98) $ (16.31)